文献速递结核与非结核分枝杆菌

新型二芳基喹啉TBAJ-876及其活性代谢物在小鼠结核模型中杀菌活性的相对贡献

Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis.
PubMed 文献 · J Infect Dis · 2024-01-01

本研究在小鼠结核模型中评估TBAJ-876及其主要活性代谢物M3对总杀菌活性的贡献。体外比较TBAJ-876、M3与贝达喹啉活性后,对感染小鼠给予TBAJ-876(1.6/6.3/25 mg/kg)或M3(3.1/12.5/50 mg/kg)进行剂量反应研究。结果显示M3暴露量高于TBAJ-876,TBAJ-876活性很大程度上归因于M3。

要点

  • TBAJ-876与M3均表现出强杀菌活性。
  • 50 mg/kg M3治疗4周的小鼠肺培养阴性。
  • TBAJ-876给药后M3暴露量较TBAJ-876高2.2至3.6倍。

核心结论

  • TBAJ-876的杀菌活性很大程度上归因于其活性代谢物M3,需考虑代谢物与母药暴露和活性差异以提高小鼠模型预测的转化价值。

研究设计与样本

  • 体外研究比较TBAJ-876、M3与贝达喹啉的活性,并在感染结核分枝杆菌的BALB/c小鼠中进行剂量反应研究,TBAJ-876剂量为1.6/6.3/25 mg/kg,M3剂量为3.1/12.5/50 mg/kg,测定肺内菌落形成单位及血浆浓度。

主要发现

  • TBAJ-876和M3均表现出强杀菌活性。
  • 50 mg/kg M3治疗4周的小鼠肺培养阴性。
  • TBAJ-876给药后M3暴露量较TBAJ-876高2.2至3.6倍。
  • 基于M3暴露量和M3处理动物的活性,TBAJ-876活性很大程度上归因于M3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: TBAJ-876 is a next-generation diarylquinoline. In vivo, diarylquinoline metabolites are formed with activity against Mycobacterium tuberculosis. Species-specific differences in parent drug-to-metabolite ratios might impact the translational value of animal model-based predictions. This study investigates the contribution of TBAJ-876 and its major active metabolite, TBAJ-876-M3 (M3), to the total bactericidal activity in a mouse tuberculosis model. METHODS: In vitro activity of TBAJ-876 and M3 was investigated and compared to bedaquiline. Subsequently, a dose-response study was conducted in M. tuberculosis-infected BALB/c mice treated with TBAJ-876 (1.6/6.3/25 mg/kg) or M3 (3.1/12.5/50 mg/kg). Colony-forming units in the lungs and TBAJ-876 and M3 plasma concentrations were determined. M3's contribution to TBAJ-876's bactericidal activity was estimated based on M3 exposure following TBAJ-876 treatment and corresponding M3 activity observed in M3-treated animals. RESULTS: TBAJ-876 and M3 demonstrated profound bactericidal activity. Lungs of mice treated for 4 weeks with 50 mg/kg M3 were culture negative. Following TBAJ-876 treatment, M3 exposures were 2.2 to 3.6-fold higher than for TBAJ-876. TBAJ-876 activity was substantially attributable to M3, given its high exposure and potent activity. CONCLUSIONS: These findings emphasize the need to consider metabolites and their potentially distinct exposure and activity profiles compared to parent drugs to enhance the translational value of mouse model-driven predictions.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mudde SE, Ammerman NC, Ten Kate MT, et al. Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis. J Infect Dis. 2024. PMID: 38941358. doi:10.1093/infdis/jiae332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。